Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Demy-Colton. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Demy-Colton or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Increasing The Stakes: Creating and Selling Your Valuation Story in Changing Times

1:13:04
 
Share
 

Manage episode 501794195 series 3685050
Content provided by Demy-Colton. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Demy-Colton or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Immune therapies and obesity treatments are getting lots of attention, and many pundits would tell you platform strategies and gene therapies have fallen out of favor. And while the Biotech Index has rebounded almost 50% from its October 2023 low, many companies are still struggling to fundraise. Our outstanding group of panelists will help distill myth from reality as they discuss how they convey their valuation story, and how they have drawn on their commercial launch experience to successfully raise capital through changing cycles and changing times.

  continue reading

25 episodes

Artwork
iconShare
 
Manage episode 501794195 series 3685050
Content provided by Demy-Colton. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Demy-Colton or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Immune therapies and obesity treatments are getting lots of attention, and many pundits would tell you platform strategies and gene therapies have fallen out of favor. And while the Biotech Index has rebounded almost 50% from its October 2023 low, many companies are still struggling to fundraise. Our outstanding group of panelists will help distill myth from reality as they discuss how they convey their valuation story, and how they have drawn on their commercial launch experience to successfully raise capital through changing cycles and changing times.

  continue reading

25 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play